Pharma Working Group meeting with OECD speaker Go back »

2014-01-21 | Shanghai

The presentation described recent trends in pharmaceutical R&P policies in OECD countries, with a focus on “value-based pricing”, based on the study published by the OECD in 2013. It stressed the most relevant aspects for China. The meeting concluded with an interactive discussion from more than 20 participants.